α-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study.

Abstract

Treatment with 0.1% brimonidine alone and 0.2% brimonidine alone, as well as combined with 2% pirenzepine, was effective in inhibiting progressing myopia. The result indicates that intraocular pressure elevation is possibly a promising mechanism and potential treatment for progressing myopia.